Ubenwa develops AI-powered software that analyzes infants' cries to identify early signs of neurological conditions, currently focusing on birth asphyxia. The company collects cry audio at partner hospitals internationally and labels recordings as normal or abnormal to build its dataset. Users record a baby crying and receive weekly summaries of patterns; the app notifies users of detected abnormalities and provides data to share with doctors. Ubenwa says it does not store raw cry recordings; analysis is matched to its existing database. The company aims to expand the technology to detect conditions such as congenital heart disease, integrate into baby monitors, and run clinical trials. To date Ubenwa has raised $2.5 million USD in a pre-seed round to fund a beta launch and begin trials.

Total raised

$2M

Funding rounds

1

Latest round

Seed

Latest activity

Jul 2022